Dierks Jeffrey's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Jan 28, 2025
- Accession no.
- 0001415889-25-002160
- Filed
- Jan 28, 2025
- Trade date
- Jan 24-27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $551.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dierks JeffreyCIK 0001821102 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2025 | Common Stock | MOption exerciseAcquired | +13,125 | $30.69 | +$402,806.25 | 13,125 | Direct | |
| Jan 24, 2025 | Common Stock | SSaleDisposed | −8,000 | $36.94 | −$295,520 | 5,125 | Direct | |
| Jan 24, 2025 | Common Stock | SSaleDisposed | −5,125 | $37.87 | −$194,083.75 | 0 | Direct | |
| Jan 24, 2025 | Common Stock | MOption exerciseAcquired | +2,687 | $0.00 | $0 | 2,687 | Direct | |
| Jan 24, 2025 | Common Stock | FTax withholdingDisposed | −1,058 | $38.01 | −$40,214.58 | 1,629 | Direct | |
| Jan 27, 2025 | Common Stock | SSaleDisposed | −1,629 | $38.02 | −$61,934.58 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2025 | Common Stock | MOption exerciseDisposed | −13,125 | $0.00 | $0 | 39,375 | Direct | |
| Jan 24, 2025 | Common Stock | MOption exerciseDisposed | −2,687 | $0.00 | $0 | 8,063 | Direct | |
| Jan 25, 2025 | Common Stock | AGrant or awardAcquired | +47,200 | $0.00 | $0 | 47,200 | Direct | |
| Jan 25, 2025 | Common Stock | AGrant or awardAcquired | +13,450 | $0.00 | $0 | 13,450 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.